Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to evaluate the safety and effectiveness of the ACP in subjects with nonvalvular atrial fibrillation by demonstrating that the device is non-inferior to optimal medical therapy (OMT) with respect to the primary effectiveness endpoint and superior to OMT with respect to primary safety endpoint.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Device | Experimental | AMPLATZER Cardiac Plug |
|
| Optimal Medical Therapy (control) | Active Comparator | Warfarin Dabigatran |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AMPLATZER Cardiac Plug | Device | AMPLATZER Cardiac Plug is a percutaneous transcatheter device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Acute Safety - Procedure Related SAEs From Randomization Through Discharge For Device Arm Only | An analysis comparing the rate of procedure related serious adverse events that occur in the device arm to a performance goal determined from literature reported rates for similar procedural techniques. The study as designed was intended to determine the difference in efficacy and safety between the device and control arm (subjects treated with OMT). However, due to early enrollment closure, the three primary endpoints were not analyzed as specified in the original trial protocol. As the Control arm subjects exited the study early, no sufficient data was available to summarize any endpoints. The three primary endpoints as mentioned in the Appendix D of the clinical investigational plan (Revision 06, dated September 2014) were summarized for the Device arm below. The secondary endpoint analysis requirement was removed from the protocol. | From Randomization to Discharge Visit |
| Long-term Safety - Device Arm Only | All-Cause Mortality and Major Bleeds Through 2 years in device arm subjects only. The study as designed was intended to determine the difference in efficacy and safety between the device and control arm (subjects treated with OMT). However, due to early enrollment closure, the three primary endpoints were not analyzed as specified in the original trial protocol. As the Control arm subjects exited the study early, no sufficient data was available to summarize any endpoints. The three primary endpoints as mentioned in the Appendix D of the clinical investigational plan (Revision 06, dated September 2014) were summarized for the Device arm. The secondary endpoint analysis requirement was removed from the protocol. | Randomization to 2 year follow-up |
| Effectiveness Endpoint - Device Arm Only | Occurrence of ischemic stroke and peripheral thromboembolism in the device arm. The study as designed was intended to determine the difference in efficacy and safety between the device and control arm (subjects treated with OMT). However, due to early enrollment closure, the three primary endpoints were not analyzed as specified in the original trial protocol. As the Control arm subjects exited the study early, no sufficient data was available to summarize any endpoints. The three primary endpoints as mentioned in the Appendix D of the clinical investigational plan (Revision 06, dated September 2014) were summarized for the Device arm. The secondary endpoint analysis requirement was removed from the protocol. |
Not provided
Not provided
Inclusion Criteria:
Summary of Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Good Samaritan Hospital | Los Angeles | California | 90017 | United States | ||
| Cedars-Sinai Medical Center |
Not provided
| Label | URL |
|---|---|
| What is Atrial Fibrillation - Fact Sheet | View source |
| Overview of Atrial Fibrillation | View source |
| Let's Talk about Stroke, TIA and Warning Signs - Fact Sheet |
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Device | AMPLATZER Cardiac Plug AMPLATZER Cardiac Plug: AMPLATZER Cardiac Plug is a percutaneous transcatheter device |
| FG001 | Optimal Medical Therapy (Control) | Warfarin Dabigatran AMPLATZER Cardiac Plug: AMPLATZER Cardiac Plug is a percutaneous transcatheter device |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Sep 23, 2014 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Randomization through 2 year follow up |
| Los Angeles |
| California |
| 90048 |
| United States |
| University of Colorado Denver | Aurora | Colorado | 80045 | United States |
| South Denver Cardiology Associates | Littleton | Colorado | 80120 | United States |
| Emory Midtown Hospital and Emory University Hospital | Atlanta | Georgia | 30308 | United States |
| St. Joseph's Hospital and Research Institute | Atlanta | Georgia | United States |
| University of Iowa Hospitals & Clinics | Iowa City | Iowa | 52242 | United States |
| University of Kentucky | Lexington | Kentucky | 40506 | United States |
| Henry Ford Hospital | Detroit | Michigan | 48202 | United States |
| Spectrum Health | Grand Rapids | Michigan | 49503 | United States |
| Providence Hospital | Southfield | Michigan | 48075 | United States |
| St. Cloud Hospital/CentraCare Heart and Vascular Clinic | Saint Cloud | Minnesota | 56303 | United States |
| HealthEast St. Joseph's Hospital | Saint Paul | Minnesota | 55102 | United States |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States |
| York Hospital | York | Pennsylvania | 17405 | United States |
| Roper Hospital/PMG Research of Charleston | Charleston | South Carolina | 29401 | United States |
| Memorial Hermann Hospital | Houston | Texas | 77030 | United States |
| Aspirus Heart & Vascular Institute | Wausau | Wisconsin | 54401 | United States |
| View source |
| COMPLETED |
|
| NOT COMPLETED |
|
|
All 97 randomized subjects were part of the baseline population.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Device | AMPLATZER Cardiac Plug AMPLATZER Cardiac Plug: AMPLATZER Cardiac Plug is a percutaneous transcatheter device |
| BG001 | Optimal Medical Therapy (Control) | Warfarin Dabigatran AMPLATZER Cardiac Plug: AMPLATZER Cardiac Plug is a percutaneous transcatheter device |
| BG002 | Total | Total of all reporting groups |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean | Standard Deviation | Years |
| |||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
| ||||||||||||||||
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
| |||||||||||||||
| CHADS2 Score | CHADS2 (Congestive heart failure, Hypertension, Age, Diabetes, Stroke or TIA )score can help doctor figure out how likely patient will have a stroke and decide if patient needs to take something to help prevent one. our score will be between 0 and 6 points: Zero: You aren't likely to have a stroke. One point: You have a medium risk of stroke. Two or more points: Your odds of having a stroke are medium to high, and your doctor probably will prescribe a blood thinner. You may hear your doctor use the medical term for that kind of medicine: oral anticoagulant. | Count of Participants | Participants |
| |||||||||||||||
| History of Atrial Fibrillation | Count of Participants | Participants |
| ||||||||||||||||
| Rhythm Status at Baseline | One subject did not have a baseline ECG performed. Hence the denominator is for 96 subjects. | Count of Participants | Participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Acute Safety - Procedure Related SAEs From Randomization Through Discharge For Device Arm Only | An analysis comparing the rate of procedure related serious adverse events that occur in the device arm to a performance goal determined from literature reported rates for similar procedural techniques. The study as designed was intended to determine the difference in efficacy and safety between the device and control arm (subjects treated with OMT). However, due to early enrollment closure, the three primary endpoints were not analyzed as specified in the original trial protocol. As the Control arm subjects exited the study early, no sufficient data was available to summarize any endpoints. The three primary endpoints as mentioned in the Appendix D of the clinical investigational plan (Revision 06, dated September 2014) were summarized for the Device arm below. The secondary endpoint analysis requirement was removed from the protocol. | No data were collected for the Control Arm/Group due to early enrollment closure and the pre-specified analysis was revised accordingly to report data for only the Device Arm. | Posted | Number | events | From Randomization to Discharge Visit |
|
|
| ||||||||||||||||||||||||||||||||||||
| Primary | Long-term Safety - Device Arm Only | All-Cause Mortality and Major Bleeds Through 2 years in device arm subjects only. The study as designed was intended to determine the difference in efficacy and safety between the device and control arm (subjects treated with OMT). However, due to early enrollment closure, the three primary endpoints were not analyzed as specified in the original trial protocol. As the Control arm subjects exited the study early, no sufficient data was available to summarize any endpoints. The three primary endpoints as mentioned in the Appendix D of the clinical investigational plan (Revision 06, dated September 2014) were summarized for the Device arm. The secondary endpoint analysis requirement was removed from the protocol. | No data were collected for the Control Arm/Group due to early enrollment closure and the pre-specified analysis was revised accordingly to report data for only the Device Arm. | Posted | Number | Events | Randomization to 2 year follow-up |
|
| |||||||||||||||||||||||||||||||||||||
| Primary | Effectiveness Endpoint - Device Arm Only | Occurrence of ischemic stroke and peripheral thromboembolism in the device arm. The study as designed was intended to determine the difference in efficacy and safety between the device and control arm (subjects treated with OMT). However, due to early enrollment closure, the three primary endpoints were not analyzed as specified in the original trial protocol. As the Control arm subjects exited the study early, no sufficient data was available to summarize any endpoints. The three primary endpoints as mentioned in the Appendix D of the clinical investigational plan (Revision 06, dated September 2014) were summarized for the Device arm. The secondary endpoint analysis requirement was removed from the protocol. | No data were collected for the Control Arm/Group due to early enrollment closure and the pre-specified analysis was revised accordingly to report data for only the Device Arm. | Posted | Number | events | Randomization through 2 year follow up |
|
|
5 Years
Abbott's internal AE coding system used for these AEs. All AEs coded as Cardiac Disorders.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Device | AMPLATZER Cardiac Plug AMPLATZER Cardiac Plug: AMPLATZER Cardiac Plug is a percutaneous transcatheter device | 7 | 68 | 52 | 68 | 61 | 68 |
| EG001 | Optimal Medical Therapy (Control) | Warfarin Dabigatran AMPLATZER Cardiac Plug: AMPLATZER Cardiac Plug is a percutaneous transcatheter device | 5 | 29 | 15 | 29 | 15 | 29 |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Abnormal Coagulation Parameter | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Abnormal Lab Value | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Acute Bronchitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Acute Erosive Gastritis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Acute Pancreatitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Acute Renal Failure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Angina Pectoris | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Arthritis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Aspiration Pneumonia/Necrotizing Pneumonia/Aspiration of Vomitus | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Atrial Fibrillation | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Atrial Flutter | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Atrial Tachycardia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Bacteremia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Bacterial Infections | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Benign Tumors | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Bleeding | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Breast Cancer | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Cancer | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Cardiac Arrest | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Cardiac Perforation* | Cardiac disorders | Company's AE Coding | Systematic Assessment | * This event was considered as sub-event of the master event for Pericardial Tamponade. |
|
| Cardiogenic Shock* | Cardiac disorders | Company's AE Coding | Systematic Assessment | * This event was considered as sub-event of the master event for Pericardial Tamponade. |
|
| Cellulitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Cerebral Aneurysm | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Cervical Stenosis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Chest Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Cholecystitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Chronic Obstructive Pulmonary Disease (COPD) | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Closed Head Injury | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Colitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Confusion | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Congestive Heart Failure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Constrictive Pericarditis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Coronary Artery Disease | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Deep Vein/Venous Thrombosis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Dehydration | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Delirium | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Device Closure of ASD | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Device Embolization | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Drug Side Effect | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Dysphagia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Dyspnea | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Ear Infection | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Elective Procedure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Elective Surgery | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Emphysema | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Empyema | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Encephalopathy | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Esophageal Laceration and Rupture | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Fall | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Fracture | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Gout | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Heart Failure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hemarthrosis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hematoma | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hemorrhagic Stroke | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hemothorax | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hip Fracture | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hydrocephalus | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hypertensive Crisis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hyponatremia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hypotension | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Ischemic Stroke | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Knee Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Low Back Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Lumbar Disc Displacement | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Lumbar Spondylosis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Melena | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Migraine | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Mononucleosis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Myocardial Infarction | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Osteoarthritis/Degenerative Joint Disease | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Other: Pancreatic pseudocyst | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Paroxysmal Atrial Fibrillation | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pericardial Effusion | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pericardial Tamponade | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pericarditis* | Cardiac disorders | Company's AE Coding | Systematic Assessment | * This event was considered as sub-event of the master event for Pericardial Tamponade. |
|
| Peripheral Arterial Occlusion | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Persistent Atrial Fibrillation | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pleural Effusion | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pneumonia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Polyneuropathy | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Presyncope | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pulmonary Embolism | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Renal Failure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Renal Insufficiency | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Respiratory Failure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Sepsis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Sick Sinus Syndrome | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Sinus Bradycardia/Sinus Bradycardia (Cardiac Arrhythmia) | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Sinusitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Spells | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Spinal Stenosis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Stroke | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Syncope | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Transient Ischemic Attack (TIA) | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Trauma | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Unstable Angina | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| VASC Bleeding | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| VASC Hematoma | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Vancomycin-Resistant Enterococcus | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Ventricular Tachycardia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Viral Gastroenteritis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Visual Disturbance | Cardiac disorders | Company's AE Coding | Systematic Assessment |
|
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Abdominal Bloating | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Abdominal Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Abnormal Coagulation Parameter | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Abnormal Lab Value | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Abnormal Renal Function | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Abrasion | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Acute Bronchitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Acute Kidney Injury | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Acute Renal Failure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Air Embolus | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Allergic Drug Reaction | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Allergy | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Anemias | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Animal Bite | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Anxiety | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Anxiety Reaction | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Aortic Aneurysms | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Aortic Valve Stranding | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Aphasia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Arm Fracture | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Arterial Hypertension/Hypertension | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Arthritis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Aspiration Pneumonia/Necrotizing Pneumonia/Aspiration of Vomitus | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Asthma | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Asymptomatic Ischemic Stroke | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Atelectasis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Atrial Fibrillation | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Atrial Flutter | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Back Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Bee Sting | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Behavior Alterations | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Bells Palsy | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Bleeding | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Bronchitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Bruise/Purpura Simplex | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Bursitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Carpal Tunnel | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Cataract | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Cellulitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Chest Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Chronic Obstructive Pulmonary Disease (COPD) | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Chronic Renal Failure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Chronic Subdural Hematoma | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Colitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Colon Polyps | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Common Cold/Upper Respiratory Tract Infection | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Compressive Effect On Nerve | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Concussion | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Congestive Heart Failure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Constipation | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Contusion | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Cough | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Decreased Appetite | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Decreased Sphincter Tone | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Dehydration | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Depression | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Device Malposition or Malfunction | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Diarrhea | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Diastolic Dysfunction | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Difficulty Catching Breath | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Diplopia/Double Vision | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Diverticulitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Dizziness | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Drug Rash | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Drug Side Effect | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Dyspepsia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Dysphagia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Dyspnea | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Earache | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Edema | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Elective Procedure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Elective Surgery | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Emesis/Vomiting | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Encephalopathy | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Epididymitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Epistaxis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Erectile Dysfunction Symptoms | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Eye Swelling | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Fall | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Fatigue/Generalized Fatigue | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Fever | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Folliculitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Fracture | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Fungal Skin Infection | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Gastritis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Gastrointestinal Bleeding | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Gastrointestinal Illness | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Gingival Bleeding | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Gout | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Headache | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Heart Failure | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Heartburn | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hemarthrosis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hematoma | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hematuria | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hemoptysis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hepatic and Biliary Disorders | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hip Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hyperkalemia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hypernatremia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hypokalemia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hypotension | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Hypoxemia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Incidental Finding of Stroke | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Intracerebral Haemorrhage | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Iron-Deficiency Anemia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Junctional Escape Rhythm/Intermittent Junctional Rhythm | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Knee Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Lacerations | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Lightheadedness | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Low Back Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Lung Crackles | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Memory Difficulty | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Microhemorrhage | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Mitral Valve Regurgitation/Mitral Insufficiency | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Musculoskeletal Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Nausea | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Neck Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Nephrolithiasis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Nocturia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Non-Specific EKG Change | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Numbness | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Onychomycosis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Overhydration | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Palpitations | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Parkinson's Disease | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Paroxysmal Atrial Fibrillation | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pericardial Effusion | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Peripheral Venous Thrombus | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Persistent Atrial Fibrillation | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Phlebitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Plantar Fasciitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pleural Effusion | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pleuretic Pain | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pneumonia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pneumothorax | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Post-Menopausal Bleeding | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pressure Sores | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Psychogenic Event | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Pulmonary Hypertension | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Ramsay Hunt Syndrome | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Rash | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Residual Interatrial Communication | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Respiratory Illness | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Rhinitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| ST Segment Changes | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Sciatica | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Shingles | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Sinus Bradycardia/Sinus Bradycardia (Cardiac Arrhythmia) | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Sinusitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Skin Cancer | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Skin Lesions | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Skin Ulcer | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Sore Throat | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Spells | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Stupor | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Syncope | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Tachycardia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Temporomandibular Joint | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Tendosynovitis | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Thrombocytopenia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Thrombus on Device | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Thyroid Disorders | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Toe Inflammation | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Transient Imbalance | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Transient Ischemic Attack (TIA) | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Trauma | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Tremor | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Uncontrolled Blood Sugar | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Unsustained/Nonsustained Ventricular Tachy/Cardiac Arrhythmia | Cardiac disorders | Company's AE Coding | Systematic Assessment | Unsustained/Nonsustained Ventricular Tachy/Cardiac Arrhythmia: Other - Non-sustained runs of VT, Ventricular Ectopic Beats/Premature Ventricular Contractions/Premature Ventricular Beats |
|
| Urinary Incontinence | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Urinary Retention | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Urinary Tract Infections | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| VASC Bleeding | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| VASC Bruise | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| VASC Hematoma | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| VASC Pseudoaneurysm | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Ventricular Tachycardia | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Vertigo | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Visual Disturbance | Cardiac disorders | Company's AE Coding | Systematic Assessment |
| |
| Weakness | Cardiac disorders | Company's AE Coding | Systematic Assessment |
|
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Sripad Bellary | Abbott | 408845814 | sripad.bellary@abbott.com |
| Apr 2, 2020 |
| Prot_SAP_000.pdf |
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| D000083242 | Ischemic Stroke |
| D020521 | Stroke |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
|
|
|
|
|
| Title | Measurements |
|---|---|
|
| Pericardial Tamponade |
|
| Cardiac Perforation* |
|
| Pericardial Effusion |
|
| Cardiogenic Shock* |
|
| Pericarditis* |
|
|
|